| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.738 | 0.019 | 0.794 | Caspase 9 stimulant | 0.794 0.012 CID_5393173 | CID_5393173 | |
| 0.714 | 0.007 | 0.755 | Aldehyde oxidase inhibitor | 0.755 0.005 CID_5393173 | CID_5393173 | |
| 0.635 | 0.005 | 0.681 | MAO inhibitor | 0.681 0.004 CID_5393173 | CID_5393173 | |
| 0.617 | 0.004 | 0.648 | MAO B inhibitor | 0.648 0.004 CID_5393173 | CID_5393173 | |
| 0.587 | 0.013 | 0.592 | 5 Hydroxytryptamine release inhibitor | 0.592 0.012 CID_5393173 | CID_5393173 | |
| 0.553 | 0.016 | 0.564 | Histamine release inhibitor | 0.564 0.014 CID_5393173 | CID_5393173 | |
| 0.5 | 0.003 | 0.747 | Macrophage migration inhibitory factor inhibitor | 0.747 0.002 CID_5393173 | CID_5393173 | |
| 0.497 | 0.004 | 0.542 | Aldehyde dehydrogenase inhibitor | 0.542 0.004 CID_5393173 | CID_5393173 | |
| 0.503 | 0.041 | 0.503 | Prostaglandin dehydrogenase inhibitor | 0.459 0.051 CID_5393173 | ||
| 0.483 | 0.031 | 0.566 | GABA C receptor rho-3 antagonist | 0.566 0.012 CID_5393173 | CID_5393173 | |
| 0.471 | 0.02 | 0.471 | Vasodilator, coronary | 0.398 0.036 CID_5393173 | ||
| 0.457 | 0.025 | 0.637 | Antioxidant | 0.637 0.009 CID_5393173 | CID_5393173 | |
| 0.463 | 0.05 | 0.572 | 15-Lipoxygenase inhibitor | 0.572 0.028 CID_5393173 | CID_5393173 | |
| 0.388 | 0.029 | 0.388 | Superoxide dismutase inhibitor | 0.369 0.032 CID_5393173 | ||
| 0.366 | 0.01 | 0.441 | MAO A inhibitor | 0.441 0.007 CID_5393173 | CID_5393173 | |
| 0.393 | 0.047 | 0.466 | Caspase 3 stimulant | 0.466 0.026 CID_5393173 | CID_5393173 | |
| 0.349 | 0.005 | 0.38 | Carbonic anhydrase XV inhibitor | 0.38 0.004 CID_5393173 | CID_5393173 | |
| 0.351 | 0.02 | 0.406 | Dual specificity phosphatase 3 inhibitor | 0.406 0.013 CID_5393173 | CID_5393173 | |
| 0.426 | 0.104 | 0.472 | Alpha-glucosidase inhibitor | 0.472 0.088 CID_5393173 | CID_5393173 | |
| 0.327 | 0.006 | 0.481 | Xanthine oxidase inhibitor | 0.481 0.004 CID_5393173 | CID_5393173 | |
| 0.324 | 0.004 | 0.324 | Sphingosine 1-phosphate receptor 2 agonist | 0.314 0.004 CID_5393173 | ||
| 0.327 | 0.01 | 0.348 | Acetylcholinesterase inhibitor | 0.348 0.009 CID_5393173 | CID_5393173 | |
| 0.361 | 0.052 | 0.438 | 12-Lipoxygenase inhibitor | 0.438 0.031 CID_5393173 | CID_5393173 | |
| 0.336 | 0.03 | 0.469 | 5 Hydroxytryptamine uptake stimulant | 0.469 0.005 CID_5393173 | CID_5393173 | |
| 0.371 | 0.07 | 0.455 | Transcription factor NF kappa B inhibitor | 0.455 0.052 CID_5393173 | CID_5393173 | |
| 0.321 | 0.025 | 0.394 | Dual specificity phosphatase inhibitor | 0.394 0.015 CID_5393173 | CID_5393173 | |
| 0.295 | 0.005 | 0.456 | Carbonic anhydrase III inhibitor | 0.456 0.004 CID_5393173 | CID_5393173 | |
| 0.394 | 0.117 | 0.508 | Apoptosis agonist | 0.508 0.072 CID_5393173 | CID_5393173 | |
| 0.3 | 0.024 | 0.363 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.363 0.011 CID_5393173 | CID_5393173 | |
| 0.312 | 0.037 | 0.312 | Cyclic AMP phosphodiesterase inhibitor | 0.27 0.054 CID_5393173 | ||
| 0.29 | 0.018 | 0.29 | Insulin sensitizer | 0.242 0.039 CID_5393173 | ||
| 0.315 | 0.043 | 0.315 | Vasodilator | 0.294 0.05 CID_5393173 | ||
| 0.325 | 0.054 | 0.42 | Hypoxia-inducible factor 1 alpha inhibitor | 0.42 0.025 CID_5393173 | CID_5393173 | |
| 0.31 | 0.049 | 0.512 | Free radical scavenger | 0.512 0.015 CID_5393173 | CID_5393173 | |
| 0.281 | 0.022 | 0.281 | Cholinergic | 0.266 0.025 CID_5393173 | ||
| 0.303 | 0.052 | 0.303 | Hypoglycemic | 0.255 0.074 CID_5393173 | ||
| 0.257 | 0.009 | 0.257 | Mediator release inhibitor | 0.238 0.01 CID_5393173 | ||
| 0.262 | 0.014 | 0.262 | Butyrylcholinesterase inhibitor | 0.26 0.014 CID_5393173 | ||
| 0.259 | 0.018 | 0.296 | Alkaline phosphatase inhibitor | 0.296 0.012 CID_5393173 | CID_5393173 | |
| 0.26 | 0.023 | 0.26 | 3C-like protease (Human coronavirus) inhibitor | 0.244 0.03 CID_5393173 | ||
| 0.312 | 0.081 | 0.312 | Calcium channel activator | 0.256 0.14 CID_5393173 | ||
| 0.273 | 0.042 | 0.273 | ErbB-1 antagonist | 0.245 0.054 CID_5393173 | ||
| 0.3 | 0.071 | 0.364 | Lipoxygenase inhibitor | 0.364 0.047 CID_5393173 | CID_5393173 | |
| 0.235 | 0.009 | 0.323 | Uric acid excretion stimulant | 0.323 0.005 CID_5393173 | CID_5393173 | |
| 0.251 | 0.032 | 0.251 | Nitric-oxide synthase stimulant | 0.235 0.044 CID_5393173 | ||
| 0.222 | 0.004 | 0.222 | Sphingosine 1-phosphate receptor 4 agonist | 0.176 0.005 CID_5393173 | ||
| 0.227 | 0.011 | 0.296 | Carbonic anhydrase XIII inhibitor | 0.296 0.006 CID_5393173 | CID_5393173 | |
| 0.254 | 0.05 | 0.366 | Nitric oxide antagonist | 0.366 0.03 CID_5393173 | CID_5393173 | |
| 0.336 | 0.146 | 0.336 | DNA polymerase beta inhibitor | 0.268 0.182 CID_5393173 | ||
| 0.228 | 0.038 | 0.228 | Tumour necrosis factor antagonist | 0.183 0.065 CID_5393173 | ||
| 0.222 | 0.034 | 0.437 | Melanin inhibitor | 0.437 0.01 CID_5393173 | CID_5393173 | |
| 0.263 | 0.074 | 0.312 | Transcription factor STAT3 inhibitor | 0.312 0.048 CID_5393173 | CID_5393173 | |
| 0.264 | 0.077 | 0.349 | Transcription factor STAT inhibitor | 0.349 0.035 CID_5393173 | CID_5393173 | |
| 0.206 | 0.026 | 0.242 | GABA C receptor rho-2 antagonist | 0.242 0.013 CID_5393173 | CID_5393173 | |
| 0.194 | 0.024 | 0.335 | Interleukin 4 antagonist | 0.335 0.007 CID_5393173 | CID_5393173 | |
| 0.194 | 0.026 | 0.446 | Cystathionine beta-synthase inhibitor | 0.446 0.004 CID_5393173 | CID_5393173 | |
| 0.275 | 0.108 | 0.275 | Cholesterol antagonist | 0.253 0.123 CID_5393173 | ||
| 0.243 | 0.078 | 0.243 | Tumour necrosis factor alpha release inhibitor | 0.205 0.104 CID_5393173 | ||
| 0.171 | 0.005 | 0.226 | Xanthine dehydrogenase inhibitor | 0.226 0.004 CID_5393173 | CID_5393173 | |
| 0.252 | 0.09 | 0.252 | Spasmolytic | 0.215 0.108 CID_5393173 | ||
| 0.198 | 0.041 | 0.293 | Interferon gamma antagonist | 0.293 0.021 CID_5393173 | CID_5393173 | |
| 0.166 | 0.012 | 0.166 | Interleukin 1 beta converting enzyme inhibitor | 0.161 0.014 CID_5393173 | ||
| 0.245 | 0.091 | 0.245 | 5 Hydroxytryptamine release stimulant | 0.205 0.117 CID_5393173 | ||
| 0.157 | 0.006 | 0.157 | Caspase 7 inhibitor | 0.135 0.01 CID_5393173 | ||
| 0.196 | 0.046 | 0.261 | Amylase inhibitor | 0.261 0.025 CID_5393173 | CID_5393173 | |
| 0.212 | 0.062 | 0.235 | Non-steroidal antiinflammatory agent | 0.235 0.049 CID_5393173 | CID_5393173 | |
| 0.162 | 0.013 | 0.213 | CYP2A6 inhibitor | 0.213 0.006 CID_5393173 | CID_5393173 | |
| 0.165 | 0.019 | 0.236 | Androgen antagonist | 0.236 0.01 CID_5393173 | CID_5393173 | |
| 0.246 | 0.1 | 0.333 | Insulysin inhibitor | 0.333 0.041 CID_5393173 | CID_5393173 | |
| 0.202 | 0.056 | 0.233 | Amyloid beta precursor protein antagonist | 0.233 0.039 CID_5393173 | CID_5393173 | |
| 0.161 | 0.016 | 0.271 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.271 0.005 CID_5393173 | CID_5393173 | |
| 0.161 | 0.016 | 0.161 | Electron transport complex I inhibitor | 0.157 0.017 CID_5393173 | ||
| 0.232 | 0.087 | 0.251 | Aryl hydrocarbon receptor agonist | 0.251 0.078 CID_5393173 | CID_5393173 | |
| 0.211 | 0.067 | 0.296 | Neurotrophic factor enhancer | 0.296 0.019 CID_5393173 | CID_5393173 | |
| 0.156 | 0.014 | 0.164 | MAP kinase kinase 1 inhibitor | 0.164 0.012 CID_5393173 | CID_5393173 | |
| 0.162 | 0.02 | 0.198 | Multidrug resistance-associated protein 1 inhibitor | 0.198 0.011 CID_5393173 | CID_5393173 | |
| 0.164 | 0.023 | 0.19 | Heat shock protein 70 antagonist | 0.19 0.008 CID_5393173 | CID_5393173 | |
| 0.145 | 0.014 | 0.259 | Aromatase inhibitor | 0.259 0.006 CID_5393173 | CID_5393173 | |
| 0.197 | 0.067 | 0.255 | Hepatoprotectant | 0.255 0.042 CID_5393173 | CID_5393173 | |
| 0.156 | 0.027 | 0.187 | Photosensitizer | 0.187 0.016 CID_5393173 | CID_5393173 | |
| 0.212 | 0.083 | 0.292 | RNA-directed DNA polymerase inhibitor | 0.292 0.033 CID_5393173 | CID_5393173 | |
| 0.302 | 0.177 | 0.302 | MAP kinase 1 inhibitor | |||
| 0.139 | 0.015 | 0.152 | Ornithine decarboxylase inhibitor | 0.152 0.01 CID_5393173 | CID_5393173 | |
| 0.29 | 0.167 | 0.29 | DNA directed DNA polymerase inhibitor | 0.24 0.198 CID_5393173 | ||
| 0.221 | 0.102 | 0.316 | Tyrosine 3 hydroxylase inhibitor | 0.316 0.026 CID_5393173 | CID_5393173 | |
| 0.141 | 0.023 | 0.249 | Carbonic anhydrase VI inhibitor | 0.249 0.009 CID_5393173 | CID_5393173 | |
| 0.169 | 0.051 | 0.169 | Toll-Like receptor 9 antagonist | 0.161 0.056 CID_5393173 | ||
| 0.199 | 0.081 | 0.303 | Pyruvate kinase inhibitor | 0.303 0.047 CID_5393173 | CID_5393173 | |
| 0.241 | 0.124 | 0.241 | Thyroid hormone beta antagonist | |||
| 0.148 | 0.031 | 0.226 | GABA C receptor antagonist | 0.226 0.009 CID_5393173 | CID_5393173 | |
| 0.182 | 0.066 | 0.214 | Succinate dehydrogenase inhibitor | 0.214 0.039 CID_5393173 | CID_5393173 | |
| 0.243 | 0.128 | 0.243 | Thyroid hormone antagonist | |||
| 0.19 | 0.076 | 0.222 | Platelet adhesion inhibitor | 0.222 0.06 CID_5393173 | CID_5393173 | |
| 0.177 | 0.066 | 0.55 | Peroxidase inhibitor | 0.55 0.006 CID_5393173 | CID_5393173 | |
| 0.167 | 0.057 | 0.251 | Protein kinase stimulant | 0.251 0.026 CID_5393173 | CID_5393173 | |
| 0.133 | 0.027 | 0.187 | Alcohol dehydrogenase inhibitor | 0.187 0.014 CID_5393173 | CID_5393173 | |
| 0.182 | 0.078 | 0.182 | P-glycoprotein inhibitor | 0.169 0.091 CID_5393173 | ||
| 0.122 | 0.019 | 0.184 | CDC25A inhibitor | 0.184 0.008 CID_5393173 | CID_5393173 | |
| 0.159 | 0.057 | 0.165 | Mannose-6-phosphate isomerase inhibitor | 0.165 0.053 CID_5393173 | CID_5393173 | |
| 0.133 | 0.034 | 0.292 | Estrogen antagonist | 0.292 0.006 CID_5393173 | CID_5393173 | |
| 0.103 | 0.004 | 0.103 | Sirtuin 2 inhibitor | 0.083 0.005 CID_5393173 | ||
| 0.183 | 0.087 | 0.383 | Amyloid beta aggregation inhibitor | 0.383 0.027 CID_5393173 | CID_5393173 | |
| 0.146 | 0.052 | 0.151 | Ca2+-transporting ATPase inhibitor | 0.151 0.04 CID_5393173 | CID_5393173 | |
| 0.236 | 0.142 | 0.305 | Apoptosis antagonist | 0.305 0.082 CID_5393173 | CID_5393173 | |
| 0.185 | 0.092 | 0.185 | Histone acetyltransferase inhibitor | 0.18 0.1 CID_5393173 | ||
| 0.112 | 0.022 | 0.112 | Granulocyte macrophage colony stimulating factor agonist | 0.104 0.029 CID_5393173 | ||
| 0.159 | 0.07 | 0.212 | Protein-tyrosine phosphatase inhibitor | 0.212 0.042 CID_5393173 | CID_5393173 | |
| 0.156 | 0.067 | 0.225 | CF transmembrane conductance regulator agonist | 0.225 0.011 CID_5393173 | CID_5393173 | |
| 0.104 | 0.015 | 0.162 | Carbonic anhydrase VB inhibitor | 0.162 0.008 CID_5393173 | CID_5393173 | |
| 0.12 | 0.032 | 0.299 | Estrogen receptor beta antagonist | 0.299 0.005 CID_5393173 | CID_5393173 | |
| 0.108 | 0.023 | 0.18 | Estrogen receptor alpha antagonist | 0.18 0.009 CID_5393173 | CID_5393173 | |
| 0.109 | 0.026 | 0.2 | Keratolytic | 0.2 0.008 CID_5393173 | CID_5393173 | |
| 0.163 | 0.08 | 0.182 | ATPase inhibitor | 0.182 0.055 CID_5393173 | CID_5393173 | |
| 0.147 | 0.065 | 0.147 | Cytokine production inhibitor | 0.11 0.1 CID_5393173 | ||
| 0.094 | 0.012 | 0.094 | Exportin-1 inhibitor | 0.085 0.019 CID_5393173 | ||
| 0.118 | 0.036 | 0.118 | Calcium antagonist | |||
| 0.094 | 0.013 | 0.187 | Fatty acid synthase inhibitor | 0.187 0.004 CID_5393173 | CID_5393173 | |
| 0.134 | 0.054 | 0.151 | Cholesterol synthesis inhibitor | 0.151 0.044 CID_5393173 | CID_5393173 | |
| 0.131 | 0.053 | 0.144 | DNA repair enzyme inhibitor | 0.144 0.037 CID_5393173 | CID_5393173 | |
| 0.121 | 0.043 | 0.233 | DOPA decarboxylase inhibitor | 0.233 0.004 CID_5393173 | CID_5393173 | |
| 0.157 | 0.08 | 0.176 | Arachidonic acid antagonist | 0.176 0.058 CID_5393173 | CID_5393173 | |
| 0.122 | 0.044 | 0.201 | Beta glucuronidase inhibitor | 0.201 0.013 CID_5393173 | CID_5393173 | |
| 0.15 | 0.074 | 0.15 | Phospholipase A2 inhibitor | 0.136 0.091 CID_5393173 | ||
| 0.117 | 0.042 | 0.147 | Breast cancer-resistant protein inhibitor | 0.147 0.025 CID_5393173 | CID_5393173 | |
| 0.109 | 0.034 | 0.213 | Topoisomerase II alpha inhibitor | 0.213 0.013 CID_5393173 | CID_5393173 | |
| 0.135 | 0.061 | 0.183 | MAP kinase kinase inhibitor | 0.183 0.035 CID_5393173 | CID_5393173 | |
| 0.092 | 0.018 | 0.124 | Androgen agonist | 0.124 0.009 CID_5393173 | CID_5393173 | |
| 0.099 | 0.027 | 0.166 | Carbonic anhydrase V inhibitor | 0.166 0.011 CID_5393173 | CID_5393173 | |
| 0.179 | 0.108 | 0.179 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.182 | 0.113 | 0.301 | Antiamyloidogenic | 0.301 0.051 CID_5393173 | CID_5393173 | |
| 0.146 | 0.078 | 0.146 | Insulin secretagoues | |||
| 0.097 | 0.029 | 0.113 | Estrogen-related receptor beta agonist | 0.113 0.013 CID_5393173 | CID_5393173 | |
| 0.106 | 0.041 | 0.106 | Phosphodiesterase 6D inhibitor | |||
| 0.125 | 0.062 | 0.142 | Beta amyloid protein antagonist | 0.142 0.047 CID_5393173 | CID_5393173 | |
| 0.071 | 0.008 | 0.071 | Sphingosine 1-phosphate receptor 1 agonist | 0.052 0.018 CID_5393173 | ||
| 0.11 | 0.049 | 0.247 | Creatine kinase inhibitor | 0.247 0.005 CID_5393173 | CID_5393173 | |
| 0.121 | 0.061 | 0.208 | Monophenol monooxygenase inhibitor | 0.208 0.031 CID_5393173 | CID_5393173 | |
| 0.11 | 0.051 | 0.127 | UDP-glucose 4-epimerase inhibitor | 0.127 0.039 CID_5393173 | CID_5393173 | |
| 0.069 | 0.013 | 0.138 | Progesterone antagonist | 0.138 0.007 CID_5393173 | CID_5393173 | |
| 0.081 | 0.027 | 0.081 | Protease 3C (Human rhinovirus) inhibitor | 0.069 0.038 CID_5393173 | ||
| 0.067 | 0.013 | 0.073 | Potassium channel (Inward rectifier) activator | 0.073 0.01 CID_5393173 | CID_5393173 | |
| 0.066 | 0.013 | 0.066 | Sphingosine 1-phosphate receptor agonist | 0.047 0.027 CID_5393173 | ||
| 0.116 | 0.064 | 0.164 | TRPA1 agonist | 0.164 0.023 CID_5393173 | CID_5393173 | |
| 0.064 | 0.013 | 0.069 | Potassium channel (ATP-sensitive) activator | 0.069 0.01 CID_5393173 | CID_5393173 | |
| 0.213 | 0.162 | 0.238 | Antithrombotic | 0.238 0.136 CID_5393173 | CID_5393173 | |
| 0.074 | 0.023 | 0.074 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.211 | 0.163 | 0.211 | Vasodilator, peripheral | 0.203 0.173 CID_5393173 | ||
| 0.123 | 0.075 | 0.177 | Papain-like protease (SARS coronavirus) inhibitor | 0.177 0.017 CID_5393173 | CID_5393173 | |
| 0.069 | 0.021 | 0.101 | Carbonic anhydrase XIV inhibitor | 0.101 0.01 CID_5393173 | CID_5393173 | |
| 0.108 | 0.061 | 0.155 | AMP-activated protein kinase stimulant | 0.155 0.025 CID_5393173 | CID_5393173 | |
| 0.064 | 0.017 | 0.064 | Squalene epoxidase inhibitor | 0.055 0.026 CID_5393173 | ||
| 0.064 | 0.018 | 0.072 | CD45 antagonist | 0.072 0.014 CID_5393173 | CID_5393173 | |
| 0.124 | 0.078 | 0.136 | Toll-Like receptor antagonist | 0.136 0.067 CID_5393173 | CID_5393173 | |
| 0.149 | 0.104 | 0.181 | Neurotensin receptor agonist | 0.181 0.049 CID_5393173 | CID_5393173 | |
| 0.092 | 0.048 | 0.092 | Transcription factor NF kappa B stimulant | 0.082 0.065 CID_5393173 | ||
| 0.122 | 0.078 | 0.153 | Cyclooxygenase 2 inhibitor | 0.153 0.052 CID_5393173 | CID_5393173 | |
| 0.064 | 0.021 | 0.064 | Sphingosine 1-phosphate receptor 5 agonist | 0.06 0.025 CID_5393173 | ||
| 0.08 | 0.037 | 0.138 | Carbonic anhydrase VA inhibitor | 0.138 0.013 CID_5393173 | CID_5393173 | |
| 0.102 | 0.06 | 0.146 | GABA C receptor rho-1 antagonist | 0.146 0.023 CID_5393173 | CID_5393173 | |
| 0.073 | 0.031 | 0.073 | Protease activated receptor antagonist | |||
| 0.149 | 0.108 | 0.2 | Phospholipase C inhibitor | 0.2 0.044 CID_5393173 | CID_5393173 | |
| 0.051 | 0.011 | 0.12 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.12 0.004 CID_5393173 | CID_5393173 | |
| 0.07 | 0.029 | 0.108 | Carbonic anhydrase XII inhibitor | 0.108 0.018 CID_5393173 | CID_5393173 | |
| 0.073 | 0.034 | 0.073 | Aryl hydrocarbon receptor antagonist | 0.07 0.038 CID_5393173 | ||
| 0.05 | 0.012 | 0.05 | Retinoid X receptor antagonist | 0.038 0.026 CID_5393173 | ||
| 0.063 | 0.026 | 0.069 | Acetyl-CoA transferase 2 inhibitor | 0.069 0.018 CID_5393173 | CID_5393173 | |
| 0.117 | 0.081 | 0.168 | Alpha-N-acetylglucosaminidase inhibitor | 0.168 0.046 CID_5393173 | CID_5393173 | |
| 0.101 | 0.066 | 0.12 | Urease inhibitor | 0.12 0.045 CID_5393173 | CID_5393173 | |
| 0.068 | 0.032 | 0.071 | Kallikrein 7 inhibitor | 0.071 0.027 CID_5393173 | CID_5393173 | |
| 0.078 | 0.044 | 0.179 | Histidine decarboxylase inhibitor | 0.179 0.015 CID_5393173 | CID_5393173 | |
| 0.045 | 0.012 | 0.045 | Free fatty acid receptor 1 antagonist | |||
| 0.045 | 0.013 | 0.045 | Vanilloid 3 antagonist | 0.038 0.027 CID_5393173 | ||
| 0.076 | 0.044 | 0.076 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.124 | 0.094 | 0.166 | Cyclooxygenase inhibitor | 0.166 0.059 CID_5393173 | CID_5393173 | |
| 0.046 | 0.016 | 0.046 | Retinoid X alpha receptor agonist | |||
| 0.104 | 0.075 | 0.138 | Protein-tyrosine phosphatase 1B inhibitor | 0.138 0.051 CID_5393173 | CID_5393173 | |
| 0.04 | 0.011 | 0.072 | Estrogen-related receptor beta antagonist | 0.072 0.004 CID_5393173 | CID_5393173 | |
| 0.085 | 0.056 | 0.141 | D-Ala-D-Ala ligase inhibitor | 0.141 0.007 CID_5393173 | CID_5393173 | |
| 0.059 | 0.031 | 0.059 | Elastase inhibitor | |||
| 0.089 | 0.062 | 0.104 | Potassium channel activator | 0.104 0.044 CID_5393173 | CID_5393173 | |
| 0.04 | 0.015 | 0.04 | Retinoid X alpha receptor antagonist | |||
| 0.061 | 0.037 | 0.083 | Carbonic anhydrase IX inhibitor | 0.083 0.026 CID_5393173 | CID_5393173 | |
| 0.094 | 0.071 | 0.125 | Anabolic | 0.125 0.035 CID_5393173 | CID_5393173 | |
| 0.128 | 0.106 | 0.128 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.037 | 0.016 | 0.037 | Cholesterol ester transfer protein antagonist | |||
| 0.05 | 0.03 | 0.05 | Aldosterone antagonist | |||
| 0.049 | 0.03 | 0.049 | Potassium channel Kv1.3 blocker | |||
| 0.038 | 0.018 | 0.067 | Estrogen-related receptor alpha antagonist | 0.067 0.01 CID_5393173 | CID_5393173 | |
| 0.066 | 0.048 | 0.066 | Acetylcholine M5 receptor agonist | |||
| 0.045 | 0.027 | 0.205 | Estradiol 17 beta-dehydrogenase inhibitor | 0.205 0.004 CID_5393173 | CID_5393173 | |
| 0.05 | 0.032 | 0.05 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.04 | 0.023 | 0.04 | Retinoid X receptor agonist | |||
| 0.22 | 0.207 | 0.371 | Antibacterial | 0.371 0.091 CID_5393173 | CID_5393173 | |
| 0.069 | 0.056 | 0.069 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.048 | 0.036 | 0.048 | Potassium channel (Inward rectifier) blocker | |||
| 0.073 | 0.064 | 0.082 | Chymotrypsin inhibitor | 0.082 0.052 CID_5393173 | CID_5393173 | |
| 0.027 | 0.018 | 0.027 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.044 | 0.035 | 0.064 | Carbonic anhydrase VII inhibitor | 0.064 0.017 CID_5393173 | CID_5393173 | |
| 0.104 | 0.095 | 0.157 | Transcription factor STAT6 inhibitor | 0.157 0.018 CID_5393173 | CID_5393173 | |
| 0.066 | 0.058 | 0.066 | Calcium channel L-type blocker | |||
| 0.06 | 0.053 | 0.083 | Transcription factor RelA inhibitor | 0.083 0.014 CID_5393173 | CID_5393173 | |
| 0.05 | 0.044 | 0.088 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.088 0.013 CID_5393173 | CID_5393173 | |
| 0.084 | 0.078 | 0.093 | DNA directed RNA polymerase inhibitor | 0.093 0.066 CID_5393173 | CID_5393173 | |
| 0.04 | 0.035 | 0.051 | GABA B receptor antagonist | 0.051 0.018 CID_5393173 | CID_5393173 | |
| 0.106 | 0.103 | 0.106 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.114 | 0.111 | 0.114 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.09 | 0.087 | 0.177 | Protein kinase (CK2) alpha inhibitor | 0.177 0.03 CID_5393173 | CID_5393173 | |
| 0.049 | 0.047 | 0.119 | Alcohol oxidase inhibitor | 0.119 0.014 CID_5393173 | CID_5393173 | |
| 0.038 | 0.036 | 0.038 | Leukocyte elastase inhibitor | |||
| 0.065 | 0.065 | 0.095 | Glycine receptor agonist | 0.095 0.024 CID_5393173 | CID_5393173 | |
| 0.063 | 0.063 | 0.099 | Cathepsin G inhibitor | 0.099 0.034 CID_5393173 | CID_5393173 | |
| 0.019 | 0.019 | 0.04 | Estrone sulfatase inhibitor | 0.04 0.009 CID_5393173 | CID_5393173 | |
| 0.103 | 0.103 | 0.119 | Bone formation stimulant | 0.119 0.086 CID_5393173 | CID_5393173 | |
| 0.075 | 0.077 | 0.083 | Thioredoxin reductase inhibitor | 0.083 0.053 CID_5393173 | CID_5393173 | |
| 0.038 | 0.041 | 0.059 | DNA gyrase subunit A inhibitor | 0.059 0.01 CID_5393173 | CID_5393173 | |
| 0.053 | 0.056 | 0.147 | HIV-1 integrase (3'-Processing) inhibitor | 0.147 0.014 CID_5393173 | CID_5393173 | |
| 0.043 | 0.046 | 0.122 | Aldose reductase inhibitor | 0.122 0.014 CID_5393173 | CID_5393173 | |
| 0.078 | 0.083 | 0.139 | 5-Lipoxygenase inhibitor | 0.139 0.042 CID_5393173 | CID_5393173 | |
| 0.033 | 0.038 | 0.038 | DNA-dependent protein kinase inhibitor | 0.038 0.031 CID_5393173 | CID_5393173 | |
| 0.054 | 0.06 | 0.077 | CDC25B inhibitor | 0.077 0.031 CID_5393173 | CID_5393173 | |
| 0.059 | 0.065 | 0.07 | Elastase 1 inhibitor | 0.07 0.047 CID_5393173 | CID_5393173 | |
| 0.041 | 0.048 | 0.055 | Glucose-6-phosphate isomerase inhibitor | 0.055 0.023 CID_5393173 | CID_5393173 | |
| 0.055 | 0.063 | 0.074 | Heme oxygenase stimulant | 0.074 0.021 CID_5393173 | CID_5393173 | |
| 0.046 | 0.054 | 0.064 | Lysine-specific demethylase 1A inhibitor | 0.064 0.023 CID_5393173 | CID_5393173 | |
| 0.083 | 0.092 | 0.101 | Bile acid receptor antagonist | 0.101 0.047 CID_5393173 | CID_5393173 | |
| 0.048 | 0.057 | 0.073 | Dihydroorotate oxidase inhibitor | 0.073 0.015 CID_5393173 | CID_5393173 | |
| 0.098 | 0.107 | 0.113 | Cyclooxygenase 3 inhibitor | 0.113 0.086 CID_5393173 | CID_5393173 | |
| 0.078 | 0.088 | 0.094 | Thioredoxin inhibitor | 0.094 0.056 CID_5393173 | CID_5393173 | |
| 0.125 | 0.136 | 0.146 | DNA methyltransferase I inhibitor | 0.146 0.109 CID_5393173 | CID_5393173 | |
| 0.086 | 0.1 | 0.097 | Mucolytic | 0.097 0.081 CID_5393173 | CID_5393173 | |
| 0.081 | 0.095 | 0.095 | Expectorant | 0.095 0.074 CID_5393173 | CID_5393173 | |
| 0.153 | 0.167 | 0.204 | DNA damaging | 0.204 0.112 CID_5393173 | CID_5393173 | |
| 0.071 | 0.087 | 0.135 | Potassium channel (Ca-activated) activator | 0.135 0.033 CID_5393173 | CID_5393173 | |
| 0.044 | 0.063 | 0.076 | Carbonic anhydrase inhibitor | 0.076 0.037 CID_5393173 | CID_5393173 | |
| 0.056 | 0.076 | 0.086 | Na+ K+ transporting ATPase inhibitor | 0.086 0.045 CID_5393173 | CID_5393173 | |
| 0.07 | 0.091 | 0.082 | Factor XII inhibitor | 0.082 0.062 CID_5393173 | CID_5393173 | |
| 0.023 | 0.045 | 0.063 | ATP citrate lysase inhibitor | 0.063 0.005 CID_5393173 | CID_5393173 | |
| 0.072 | 0.094 | 0.165 | Protein kinase (CK2) inhibitor | 0.165 0.027 CID_5393173 | CID_5393173 | |
| 0.023 | 0.047 | 0.051 | Catechol O-methyltransferase inhibitor | 0.051 0.008 CID_5393173 | CID_5393173 | |
| 0.071 | 0.098 | 0.108 | NADH dehydrogenase inhibitor | 0.108 0.037 CID_5393173 | CID_5393173 | |
| 0.03 | 0.057 | 0.143 | Estrogen agonist | 0.143 0.012 CID_5393173 | CID_5393173 | |
| 0.087 | 0.116 | 0.147 | Cyclooxygenase 1 inhibitor | 0.147 0.058 CID_5393173 | CID_5393173 | |
| 0.093 | 0.126 | 0.158 | NADPH oxidase inhibitor | 0.158 0.05 CID_5393173 | CID_5393173 | |
| 0.01 | 0.044 | 0.067 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.067 0.005 CID_5393173 | CID_5393173 | |
| 0.07 | 0.104 | 0.098 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.098 0.056 CID_5393173 | CID_5393173 | |
| 0.061 | 0.098 | 0.075 | Vanilloid 4 agonist | 0.075 0.051 CID_5393173 | CID_5393173 | |
| 0.01 | 0.048 | 0.154 | Estrogen receptor beta agonist | 0.154 0.007 CID_5393173 | CID_5393173 | |
| 0.023 | 0.064 | 0.056 | Urate transporter 1 inhibitor | 0.056 0.015 CID_5393173 | CID_5393173 | |
| 0.066 | 0.111 | 0.086 | Triose-phosphate isomerase inhibitor | 0.086 0.065 CID_5393173 | CID_5393173 | |
| 0.073 | 0.12 | 0.191 | Topoisomerase II inhibitor | 0.191 0.035 CID_5393173 | CID_5393173 | |
| 0.108 | 0.155 | 0.138 | Adenylate cyclase stimulant | 0.138 0.085 CID_5393173 | CID_5393173 | |
| 0.087 | 0.135 | 0.183 | Lipid peroxidase inhibitor | 0.183 0.049 CID_5393173 | CID_5393173 | |
| 0.021 | 0.069 | 0.032 | Inosine monophosphate dehydrogenase inhibitor | 0.032 0.031 CID_5393173 | CID_5393173 | |
| 0.03 | 0.082 | 0.039 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.039 0.036 CID_5393173 | CID_5393173 | |
| 0.033 | 0.086 | 0.101 | HIV-1 integrase (Strand Transfer) inhibitor | 0.101 0.022 CID_5393173 | CID_5393173 | |
| 0.038 | 0.091 | 0.084 | Phosphofructokinase-1 inhibitor | 0.084 0.039 CID_5393173 | CID_5393173 | |
| 0.042 | 0.096 | 0.083 | Phenylalanine 4-hydroxylase inhibitor | 0.083 0.036 CID_5393173 | CID_5393173 | |
| 0.084 | 0.14 | 0.144 | Toll-Like receptor 2 antagonist | 0.144 0.057 CID_5393173 | CID_5393173 | |
| 0.116 | 0.179 | 0.25 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.25 0.067 CID_5393173 | CID_5393173 | |
| 0.098 | 0.162 | 0.13 | Farnesoid X receptor antagonist | 0.13 0.082 CID_5393173 | CID_5393173 | |
| 0.035 | 0.101 | 0.059 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.059 0.04 CID_5393173 | CID_5393173 | |
| 0.097 | 0.166 | 0.179 | Heat shock protein 90 antagonist | 0.179 0.049 CID_5393173 | CID_5393173 | |
| 0.122 | 0.192 | 0.162 | Catenin beta inhibitor | 0.162 0.081 CID_5393173 | CID_5393173 | |
| 0.045 | 0.116 | 0.079 | Potassium channel large-conductance Ca-activated activator | 0.079 0.035 CID_5393173 | CID_5393173 | |
| 0.036 | 0.108 | 0.08 | Lipase inhibitor | 0.08 0.043 CID_5393173 | CID_5393173 | |
| 0.058 | 0.134 | 0.122 | Prolactin inhibitor | 0.122 0.037 CID_5393173 | CID_5393173 | |
| 0.088 | 0.168 | 0.142 | Mcl-1 antagonist | 0.142 0.098 CID_5393173 | CID_5393173 | |
| 0.042 | 0.122 | 0.09 | Histone deacetylase SIRT1 stimulant | 0.09 0.035 CID_5393173 | CID_5393173 | |
| 0.042 | 0.122 | 0.09 | Histone deacetylase stimulant | 0.09 0.035 CID_5393173 | CID_5393173 | |
| 0.142 | 0.222 | 0.214 | DNA synthesis inhibitor | 0.214 0.103 CID_5393173 | CID_5393173 | |
| 0.102 | 0.184 | 0.141 | MAP kinase kinase 2 inhibitor | 0.141 0.13 CID_5393173 | CID_5393173 | |
| 0.005 | 0.087 | 0.071 | Estrogen receptor alpha agonist | 0.071 0.013 CID_5393173 | CID_5393173 | |
| 0.055 | 0.138 | 0.097 | Protein kinase C delta inhibitor | 0.097 0.055 CID_5393173 | CID_5393173 | |
| 0.044 | 0.128 | 0.071 | Glutamate (mGluR7) antagonist | 0.071 0.04 CID_5393173 | CID_5393173 | |
| 0.062 | 0.147 | 0.14 | Chelator | 0.14 0.04 CID_5393173 | CID_5393173 | |
| 0.06 | 0.148 | 0.081 | mTOR complex 2 inhibitor | 0.081 0.067 CID_5393173 | CID_5393173 | |
| 0.035 | 0.129 | 0.105 | Porphobilinogen synthase inhibitor | 0.105 0.033 CID_5393173 | CID_5393173 | |
| 0.037 | 0.133 | 0.054 | Heat shock protein 90 beta antagonist | 0.054 0.051 CID_5393173 | CID_5393173 | |
| 0.017 | 0.113 | 0.059 | Dopamine D5 agonist | 0.059 0.012 CID_5393173 | CID_5393173 | |
| 0.102 | 0.205 | 0.225 | Dyrk kinase inhibitor | 0.225 0.084 CID_5393173 | CID_5393173 | |
| 0.082 | 0.186 | 0.141 | Cell wall synthesis inhibitor | 0.141 0.074 CID_5393173 | CID_5393173 | |
| 0.116 | 0.221 | 0.168 | Streptokinase A inhibitor | 0.168 0.156 CID_5393173 | CID_5393173 | |
| 0.041 | 0.151 | 0.056 | Ryanodine receptor antagonist | 0.056 0.052 CID_5393173 | CID_5393173 | |
| 0.044 | 0.159 | 0.117 | Topoisomerase I inhibitor | 0.117 0.057 CID_5393173 | CID_5393173 | |
| 0.04 | 0.164 | 0.076 | Myeloperoxidase inhibitor | 0.076 0.075 CID_5393173 | CID_5393173 | |
| 0.029 | 0.175 | 0.083 | Glutamate decarboxylase inhibitor | 0.083 0.042 CID_5393173 | CID_5393173 | |
| 0.037 | 0.187 | 0.086 | HIV-1 integrase inhibitor | 0.086 0.034 CID_5393173 | CID_5393173 | |
| 0.059 | 0.21 | 0.079 | CC chemokine 5 receptor agonist | 0.079 0.067 CID_5393173 | CID_5393173 | |
| 0.018 | 0.172 | 0.031 | Protein kinase (CK2) beta inhibitor | 0.031 0.028 CID_5393173 | CID_5393173 | |
| 0.026 | 0.187 | 0.049 | Topoisomerase II beta inhibitor | 0.049 0.035 CID_5393173 | CID_5393173 | |
| 0.045 | 0.207 | 0.123 | GABA C receptor agonist | 0.123 0.047 CID_5393173 | CID_5393173 | |
| 0.078 | 0.242 | 0.175 | NOS3 expression enhancer | 0.175 0.053 CID_5393173 | CID_5393173 | |
| 0.061 | 0.228 | 0.123 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.123 0.103 CID_5393173 | CID_5393173 | |
| 0.13 | 0.309 | 0.256 | Sodium/bile acid cotransporter inhibitor | 0.256 0.122 CID_5393173 | CID_5393173 | |
| 0.032 | 0.214 | 0.074 | GABA aminotransferase inhibitor | 0.074 0.054 CID_5393173 | CID_5393173 | |
| 0.074 | 0.26 | 0.137 | Interleukin antagonist | 0.137 0.129 CID_5393173 | CID_5393173 | |
| 0.177 | 0.369 | 0.368 | Antiinflammatory | 0.368 0.16 CID_5393173 | CID_5393173 | |
| 0.065 | 0.286 | 0.129 | Hexokinase inhibitor | 0.129 0.105 CID_5393173 | CID_5393173 | |
| 0.007 | 0.229 | 0.049 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.049 0.016 CID_5393173 | CID_5393173 | |
| 0.063 | 0.286 | 0.131 | Heat shock protein 90 alpha antagonist | 0.131 0.111 CID_5393173 | CID_5393173 | |
| 0.023 | 0.249 | 0.046 | CXC chemokine 1 receptor antagonist | 0.046 0.045 CID_5393173 | CID_5393173 | |
| 0.096 | 0.332 | 0.126 | CC chemokine 6 receptor antagonist | 0.126 0.086 CID_5393173 | CID_5393173 | |
| 0.04 | 0.298 | 0.077 | MAP kinase kinase 7 inhibitor | 0.077 0.055 CID_5393173 | CID_5393173 | |
| 0.13 | 0.465 | 0.244 | Calcium channel L-type activator | 0.244 0.212 CID_5393173 | CID_5393173 | |
| 0.073 | 0.409 | 0.132 | MAP kinase kinase 4 inhibitor | 0.132 0.108 CID_5393173 | CID_5393173 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |